Genomics meets immunity in pancreatic cancer: Current research and future directions for pancreatic adenocarcinoma immunotherapy

Pancreatic adenocarcinoma (PDAC) remains a formidable disease that needs improved therapeutic strategies. Even though immunotherapy has revolutionized treatment for various solid tumor types, it remains largely ineffective in treating individuals with PDAC. This review describes how the application...

Descripción completa

Detalles Bibliográficos
Autores principales: Bowers, Jacob S., Bailey, Stefanie R., Rubinstein, Mark P., Paulos, Chrystal M., Camp, E. Ramsay
Formato: Online Artículo Texto
Lenguaje:English
Publicado: PAGEPress Publications, Pavia, Italy 2019
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6686121/
https://www.ncbi.nlm.nih.gov/pubmed/31456872
http://dx.doi.org/10.4081/oncol.2019.430

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6686121/
https://www.ncbi.nlm.nih.gov/pubmed/31456872
http://dx.doi.org/10.4081/oncol.2019.430

Ejemplares similares